INTELLECTUAL PROPERTY SECURITY AGREEMENTIntellectual Property Security Agreement • June 19th, 2002 • Immune Response Corp • Biological products, (no disgnostic substances)
This Intellectual Property Security Agreement is entered into as of January , 2002 by and between TRANSAMERICA TECHNOLOGY FINANCE CORPORATION successor in interest to TRANSAMERICA BUSINESS CREDIT CORPORATION, a Delaware corporation, ("TTFC") and THE IMMUNE RESPONSE CORPORATION, a Delaware corporation, and I.R.C. INC. (The Immune Response Corporation and I.R.C. Inc. collectively referred to as "Grantor"), with reference to the following facts:
Security AgreementSecurity Agreement • June 19th, 2002 • Immune Response Corp • Biological products, (no disgnostic substances) • Illinois
THIS SECURITY AGREEMENT is entered into as of the above date, between The Immune Response Corporation having chief executive office and principal place of business at the address above, and I.R.C. Inc. having chief executive office and principal place of business at the address shown above, (The Immune Response Corporation and I.R.C. Inc. collectively referred to as the "Borrower"), and TRANSAMERICA TECHNOLOGY FINANCE CORPORATION, successor in interest to Transamerica Business Credit Corporation, a Delaware corporation, ("TTFC") having its principal office at 9399 West Higgins Road, Suite 600, Rosemont, Illinois 60018 and having an office at 76 Batterson Park Road, Farmington, Connecticut 06032. (Definitions of certain terms used in this Agreement are set forth in Section 6 below.) This Security Agreement supplements that certain Master Loan and Security Agreement dated September 30, 1999, as amended from time to time between Borrower, and Transamerica Business Credit Corporation (and
AGREEMENTAgreement • June 19th, 2002 • Immune Response Corp • Biological products, (no disgnostic substances) • Illinois
THIS AGREEMENT (this "Agreement") dated as of January 1, 2002 is made by and between THE IMMUNE RESPONSE CORPORATION, a corporation organized under the laws of Delaware and I.R.C. Inc., a corporation organized under the laws of Delaware (The Immune Response Corporation and I.R.C. Inc. collectively referred to as "Borrower") and TRANSAMERICA TECHNOLOGY FINANCE CORPORATION successor in interest to TRANSAMERICA BUSINESS CREDIT CORPORATION, a Delaware corporation ("TTFC").
INTERCREDITOR AGREEMENTIntercreditor Agreement • June 19th, 2002 • Immune Response Corp • Biological products, (no disgnostic substances) • New York
INTERCREDITOR AGREEMENT (this "Agreement), dated as of June 11, 2002, by and among Transamerica Technology Finance Corporation, a Delaware corporation and successor in interest to Transamerica Business Credit Corporation ("Transamerica"), The Immune Response Corporation, a Delaware corporation (the "Company"), Kevin Kimberlin Partners, L.P., a Delaware limited partnership ("KKP"), and Oshkim Limited Partnership, a Nevada limited partnership ("Oshkim").
